{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:42:43Z","timestamp":1790790163440,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.yebeh.2026.110920","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T16:18:07Z","timestamp":1771690687000},"page":"110920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Use of fenfluramine in MECP2-related Rett syndrome: Findings from a retrospective multicenter pediatric case series"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-8936","authenticated-orcid":false,"given":"Silvia","family":"Boeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Cognolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Simonetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Ratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Federica","family":"Pelizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5316-8055","authenticated-orcid":false,"given":"Giulia","family":"Stevanato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0491-4021","authenticated-orcid":false,"given":"Domenica","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Quintiliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Quartana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Pitino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6634-2474","authenticated-orcid":false,"given":"Giulia","family":"Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.110920_b0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett\u2019s syndrome: Report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13643-023-02169-6","article-title":"Global prevalence of Rett syndrome: systematic review and meta-analysis","volume":"12","author":"Petriti","year":"2023","journal-title":"Syst Rev"},{"key":"10.1016\/j.yebeh.2026.110920_b0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.yebeh.2026.110920_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00018","article-title":"Developmental and maintenance defects in Rett syndrome neurons identified by a new mouse staging system in vitro","volume":"8","author":"Baj","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2026.110920_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41597-020-00794-7","article-title":"A catalogue of 863 Rett-syndrome-causing MECP2 mutations and lessons learned from data integration","volume":"8","author":"Ehrhart","year":"2021","journal-title":"Sci Data"},{"key":"10.1016\/j.yebeh.2026.110920_b0030","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.yebeh.2026.110920_b0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.braindev.2008.04.007","article-title":"Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant)","volume":"31","author":"Renieri","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2026.110920_b0045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0387-7604(85)80037-1","article-title":"The clinical pattern of the rett syndrome","volume":"7","author":"Hanefeld","year":"1985","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2026.110920_b0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0387-7604(85)80030-9","article-title":"Rett syndrome: Report of eight cases","volume":"7","author":"Rolando","year":"1985","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2026.110920_b0055","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/epi.12941","article-title":"Epilepsy in Rett syndrome\u2014Lessons from the Rett networked database","volume":"56","author":"Nissenkorn","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.110920_b0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejpn.2016.03.010","article-title":"The role of transcranial magnetic stimulation in evaluation of motor cortex excitability in Rett syndrome","volume":"20","author":"Krajnc","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0065","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1528-1167.2012.03656.x","article-title":"Epilepsy in Rett syndrome, and CDKL5 - and FOXG1 -gene-related encephalopathies","volume":"53","author":"Guerrini","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.110920_b0070","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yebeh.2010.06.051","article-title":"Epilepsy in Rett syndrome: clinical and genetic features","volume":"19","author":"Pintaudi","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.110920_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/155005948701800407","article-title":"Rett\u2019s syndrome with Lennox-Gastaut pattern","volume":"18","author":"Garcia","year":"1987","journal-title":"Clin Electroencephalogr"},{"key":"10.1016\/j.yebeh.2026.110920_b0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/dmcn.14822","article-title":"Fenfluramine as antiseizure medication for epilepsy","volume":"63","author":"Gogou","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-023-01881-w","article-title":"Fenfluramine: a Review in Dravet and Lennox-Gastaut Syndromes","volume":"83","author":"Frampton","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2026.110920_b0090","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/epi.18020","article-title":"Comprehensive scoping review of fenfluramine\u2019s role in managing generalized tonic\u2013clonic seizures in developmental and epileptic encephalopathies","volume":"65","author":"Gil-Nagel","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.110920_b0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/epi.17431","article-title":"Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox\u2013Gastaut syndrome: Interim analysis of an open\u2010label extension study","volume":"64","author":"Knupp","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.110920_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1192022","article-title":"Fenfluramine: a plethora of mechanisms?","volume":"14","author":"Sourbron","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.yebeh.2026.110920_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/epi.16923","article-title":"Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder","volume":"62","author":"Devinsky","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.110920_b0110","unstructured":"https:\/\/rettsyndromenews.com\/news\/anavex-2-73-shows-promise-rett-children-but-misses-trial-goal\/. 2025. 18\/01\/2026."},{"key":"10.1016\/j.yebeh.2026.110920_b0115","unstructured":"Elena Gonzalez-Alguacil, Nuria Lamagrande Casanova, Anna Duat Rodr\u00edguez, Juan Jose Garc\u00eda Pe\u00f1as, V\u00edctor Soto Insuga, Cristina Benitez Provedo, et al. Preliminary Evidence on the Use of Fenfluramine in Patients with Rett Syndrome and Associated Epilepsy. Epilepsy Society Congress . 2024."},{"key":"10.1016\/j.yebeh.2026.110920_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2020-000717","article-title":"Consensus guidelines on managing Rett syndrome across the lifespan","volume":"4","author":"Fu","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.yebeh.2026.110920_b0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00415-025-13135-8","article-title":"Fenfluramine: an effective treatment for developmental epileptic encephalopathies beyond Dravet and Lennox-Gastaut Syndromes","volume":"272","author":"Soto-Insuga","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0130","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2026.110920_b0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for Treatment-Resistant Seizures in patients with Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: a Randomized Clinical Trial","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2025.107687","article-title":"Fenfluramine for developmental and epileptic encephalopathy with spike-wave activation in sleep (DEE-SWAS): an exploratory study","volume":"218","author":"Parra-D\u00edaz","year":"2025","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.110920_b0145","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dmcn.15492","article-title":"Follow-up to low-dose fenfluramine for Sunflower syndrome: anon-randomized controlled trial","volume":"65","author":"Patel","year":"2023","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0150","article-title":"SCN1B Genetic Variants: a Review of the Spectrum of Clinical Phenotypes and a Report of Early Myoclonic Encephalopathy","volume":"9","author":"Zhu","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.yebeh.2026.110920_b0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/dmcn.14965","article-title":"Fenfluramine for seizures associated with Sunflower syndrome","volume":"63","author":"Geenen","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/adc.65.1.112","article-title":"Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial","volume":"65","author":"Selikowitz","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2026.110920_b0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF02211879","article-title":"Effects of fenfluramine on social behavior in autistic children","volume":"18","author":"Reiss","year":"1988","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2026.110920_b0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF02212855","article-title":"Fenfluramine treatment of twenty children with autism","volume":"19","author":"Ekman","year":"1989","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2026.110920_b0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01837901","article-title":"Brief report: Effects of fenfluramine on behavioral, cognitive, and affective disturbances in autistic children","volume":"15","author":"August","year":"1985","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2026.110920_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108024","article-title":"Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children\/young adults with Dravet syndrome","volume":"121","author":"Bishop","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.110920_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106989","article-title":"Fenfluramine acts as a positive modulator of sigma-1 receptors","volume":"105","author":"Martin","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.110920_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110753","article-title":"Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers","volume":"173","author":"Knupp","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.110920_b0195","volume":"12","author":"Fattorusso","year":"2021","journal-title":"The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies Front Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pediatrneurol.2025.03.001","article-title":"A Postmarketing Pharmacovigilance Study of Fenfluramine: adverse Event Data Mining and Analysis based on the US Food and Drug Administration Public Data Open Project (openFDA)","volume":"166","author":"Chen","year":"2025","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.110920_b0205","unstructured":"Tim A Benke, Scott Demarest, Katie Angione, Jenny Downs, Helen Leonard, Jacinta Saldaris, et al. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK602610\/. 2025. 16\/01\/2026."},{"key":"10.1016\/j.yebeh.2026.110920_b0210","unstructured":"https:\/\/www.rettsyndrome.org\/about-rett-syndrome\/pipeline\/. 18\/01\/2026."}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:53:08Z","timestamp":1773046388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"alternative-id":["S1525505026000417"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110920","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of fenfluramine in MECP2-related Rett syndrome: Findings from a retrospective multicenter pediatric case series","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110920"}}